Evidence mapPaperPMID 41100182Full record

ArticleJCI insight2025

Ryanodine receptor 2-mediated calcium leak is associated with increased glyoxalase I in the aging brain.

Elizabeth Woo, Dibyadeep Datta, Shveta Bathla, Hannah Beatty, Pinar Caglayan, Ashley Kristant Albizu, TuKiet T Lam, Jean Kanyo, Mary Kate Joyce, Shannon Leslie and 13 more

Abstract read
In one paragraph

Article in JCI insight, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Elizabeth WooInterdepartmental Neuroscience Program, and.
Dibyadeep DattaDepartment of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.
Shveta BathlaDepartment of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.
Hannah BeattyUniversity of Colorado School of Medicine, Aurora, Colorado, USA.
Pinar CaglayanUniversity of Rochester School of Medicine and Dentistry, Rochester, New York, USA.
Ashley Kristant AlbizuDepartment of Comparative Medicine.
TuKiet T LamKeck MS & Proteomics Resource, and.
Jean KanyoKeck MS & Proteomics Resource, and.
Mary Kate JoyceBoston University, Boston, Massachusetts, USA.
Shannon LeslieJohnson & Johnson Innovative Medicine, San Diego, California, USA.
Stacy UchenduInterdepartmental Neuroscience Program, and.
Jonathan DeLongDepartments of Neurology and Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA.
Qinyue Stacy GuanGeisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.
Jiaxin LiDepartments of Neurology and Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA.
Efrat AbramsonInterdepartmental Neuroscience Program, and.
Alison L HermanUniversity of Michigan Medical School, Ann Arbor, Michigan, USA.
Dawson CooperUniversity of Minnesota Medical School, Minneapolis, Minnesota, USA.
Pawel LicznerskiDepartment of Internal Medicine, Section of Endocrinology, Yale University School of Medicine, New Haven, Connecticut, USA.
Tamas L HorvathDepartment of Comparative Medicine.
Elizabeth A JonasDepartment of Internal Medicine, Section of Endocrinology, Yale University School of Medicine, New Haven, Connecticut, USA.
Angus C NairnDepartment of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.
Amy Ft ArnstenDepartment of Neuroscience, Yale University School of Medicine, New Haven, Connecticut, USA.
Lauren H SansingDepartments of Neurology and Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA.

Funding

INTERDISCIPLINARY IMMUNOLOGY TRAINING PROGRAMT32AI007019 · YALE UNIVERSITY · 1985 to 2025
$3.8M
Medical Scientist Training ProgramT32GM136651 · YALE UNIVERSITY · 2025 to 2025
$2.3M
Preclinical assessment of GCPII inhibitors for cognition and tau pathologyR01AG061190 · NIA · YALE UNIVERSITY · PI AMY F.T. ARNSTEN · 2022 to 2023
$1.4M
NIAID NIH HHS T32 AI007019NIA NIH HHS F30 AG074629NIA NIH HHS R01 AG061190NIGMS NIH HHS T32 GM136651
6 · The paper itself

Abstract

Alzheimer disease (AD) is characterized by plaques and tangles, including calcium dysregulation and glycated products produced by reactive carbonyl compounds. AD brains have increased glyoxalase I (GLO1), a major scavenger of inflammatory carbonyl compounds, at early, but not later, stages of disease. Calcium dysregulation includes calcium leak from phosphorylated ryanodine receptor 2 (pS2808-RyR2), seen in aged macaques and AD mouse models, but the downstream consequences of calcium leak remain unclear. Here, we show that chronic calcium leak is associated with increased GLO1 expression and activity. In macaques, we found age-related increases in GLO1 expression in the prefrontal cortex (PFC), correlating with pS2808-RyR2, and localized to dendrites and astrocytes. To examine the relationship between GLO1 and RyR2, we used S2808D-RyR2 mutant mice exhibiting chronic calcium leak through RyR2, and found increased GLO1 expression and activity in the PFC and hippocampus as early as 1 month and as late as 21 months of age, with a bell-shaped aging curve. These aged S2808D-RyR2 mice demonstrated impaired working memory. As with macaques, GLO1 was expressed in astrocytes and neurons. Proteomics data generated from S2808D-RyR2 synaptosomes confirmed GLO1 upregulation. Altogether, these data suggest potential association between GLO1 and chronic calcium leak, providing resilience in early stages of aging.

Indexed as

AgingAlzheimer DiseaseBrainCalciumLactoylglutathione LyaseRyanodine Receptor Calcium Release ChannelAnimalsAstrocytesDisease Models, AnimalFemaleHippocampusHumansMaleMicePrefrontal CortexCalciumGlo1 protein, mouseLactoylglutathione Lyaseryanodine receptor 2. mouseRyanodine Receptor Calcium Release ChannelAgingAlzheimer diseaseCalciumNeuroscienceProteomics

Identifiers

PMID41100182
PMCPMC12643534

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.